Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

Autor: Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ionescu MC; UK Health Security Agency, London, UK., Tilby M; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Little M; Oxford University Hospitals NHS Trust, Oxford, UK., Burke E; Oxford University Hospitals NHS Trust, Oxford, UK., Fittall MW; Cancer Institute, University College London, London, UK., Khan S; University of Leicester, Leicester, UK., Liu JKH; University of Leeds, Leeds, UK., Platt JR; Leeds Institute of Medical Research at St James's, Leeds, UK., Mew R; Torbay and South Devon NHS Foundation Trust, Torquay, UK., Tripathy AR; Queen Elizabeth Hospital Birmingham, Birmingham, UK., Watts I; Royal Free London NHS Foundation Trust, London, UK., Williams ST; University of Sheffield, Sheffield, UK., Appanna N; Oxford Medical School, University of Oxford, Oxford, UK., Al-Hajji Y; Birmingham Medical School, University of Birmingham, Birmingham, UK., Barnard M; UK Health Security Agency, London, UK., Benny L; UK Health Security Agency, London, UK., Burnett A; Weston Park Cancer Centre, Sheffield, UK., Bytyci J; Department of Oncology, University of Oxford, Oxford, UK., Cattell EL; Taunton and Somerset NHS Foundation Trust, Taunton, UK., Cheng V; University of Leeds, Leeds, UK., Clark JJ; Imperial College London, London, UK., Eastlake L; Royal Cornwall Hospital Trust, Truro, UK., Gerrand K; UK Health Security Agency, London, UK., Ghafoor Q; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Grumett S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Harper-Wynne C; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Kahn R; Blood Cancer UK, London, UK., Lee AJX; University College London, London, UK., Lomas O; Oxford University Hospitals NHS Trust, Oxford, UK., Lydon A; Torbay and South Devon NHS Foundation Trust, Torquay, UK., Mckenzie H; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Panneerselvam H; Wye Valley NHS Trust, Hereford, UK., Pascoe JS; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Patel G; University College London, London, UK., Patel V; National Health Service, London, UK., Potter VA; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Randle A; Royal College of Physicians, London, UK., Rigg AS; Guy's and St Thomas' NHS Foundation Trust, London, UK., Robinson TM; University of Bristol, Bristol, UK., Roylance R; University College London Hospitals NHS Foundation Trust, London, UK., Roques TW; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Rozmanowski S; UK Health Security Agency, London, UK., Roux RL; Oxford University Hospitals NHS Trust, Oxford, UK., Shah K; Oxford University Hospitals NHS Trust, Oxford, UK., Sheehan R; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Sintler M; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Swarup S; Department of Oncology, University of Oxford, Oxford, UK., Taylor H; Oxford Medical School, University of Oxford, Oxford, UK., Tillett T; Royal United Hospital Bath NHS Trust, Bath, UK., Tuthill M; Oxford University Hospitals NHS Trust, Oxford, UK., Williams S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Ying Y; Department of Oncology, University of Oxford, Oxford, UK., Beggs A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Iveson T; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Lee SM; University College London Hospitals NHS Foundation Trust, London, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Middleton M; Department of Oncology, University of Oxford, Oxford, UK., Protheroe A; Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Fowler T; UK Health Security Agency, London, UK.; William Harvey Research Institute, London, UK., Johnson P; University of Southampton, Southampton, UK., Lee LYW; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. lennard.lee@oncology.ox.ac.uk.; Department of Oncology, University of Oxford, Oxford, UK. lennard.lee@oncology.ox.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2023 Jul 25; Vol. 13 (1), pp. 11327. Date of Electronic Publication: 2023 Jul 25.

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Autor: Lee LYW; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom., Tilby M; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom., Ionescu MC; UK Health Security Agency, London, United Kingdom., Burnett A; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Hattersley R; Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom., Khan S; University of Leicester, Leicester, United Kingdom., Little M; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Liu JKH; University of Leeds, Leeds, West Yorkshire, United Kingdom., Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom., Tripathy A; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom., Watts I; Royal Free Hospital, London, United Kingdom., Williams ST; University of Sheffield, Sheffield, United Kingdom., Appanna N; University of Oxford, Oxford, United Kingdom., Al-Hajji Y; Birmingham Medical School, University of Birmingham, Birmingham, United Kingdom., Barnard M; UK Health Security Agency, London, United Kingdom., Benny L; UK Health Security Agency, London, United Kingdom., Buckley A; UK Health Security Agency, London, United Kingdom., Cattell E; NHS England, Leeds, United Kingdom., Cheng V; University of Leeds, Leeds, West Yorkshire, United Kingdom., Clark J; Imperial College London, London, United Kingdom., Eastlake L; Royal Cornwall Hospitals Trust, Truro, United Kingdom., Gerrand K; UK Health Security Agency, London, United Kingdom., Ghafoor Q; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Grumett S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Harper-Wynne C; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom., Kahn R; Blood Cancer UK, Edinburgh, United Kingdom., Lee AJX; University College London, London, United Kingdom., Lydon A; Torbay and South Devon NHS Trust, Torquay, United Kingdom., McKenzie H; University Hospital Southampton, Southampton, United Kingdom., Panneerselvam H; Wye Valley NHS Foundation Trust, Herefordshire, United Kingdom., Pascoe J; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Patel G; Kent Oncology Centre, Maidstone, United Kingdom., Patel V; NHS England, Leeds, United Kingdom., Potter V; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom., Randle A; Royal College of Physicians, London, United Kingdom., Rigg AS; Guy's and St Thomas' Hospitals NHS Trust, London, United Kingdom., Robinson T; University of Bristol, Bristol, United Kingdom., Roylance R; University College London Hospitals NHS Foundation Trust, London, United Kingdom., Roques T; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norfolk, United Kingdom., Rozmanowski S; UK Health Security Agency, London, United Kingdom., Roux RL; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Shah K; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Sintler M; Sandwell and West Birmingham Hospitals NHS Trust, United Kingdom., Taylor H; Oxford Medical School, University of Oxford, Oxford, United Kingdom., Tillett T; Royal United Hospitals Bath, Bath, United Kingdom., Tuthill M; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Williams S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Beggs A; Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom., Iveson T; Department of Oncology, Southampton University Hospitals, Southampton, United Kingdom., Lee SM; UCLH/CRUK Lung Cancer Centre of Excellence, London, United Kingdom., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Middleton M; Department of Oncology, University of Oxford, Oxford, United Kingdom., Protheroe AS; Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom., Fittall MW; Royal Marsden NHS Foundation Trust, United Kingdom., Fowler T; William Harvey Research Institute, London, United Kingdom., Johnson P; University of Southampton, United Kingdom.

Publikováno v: JAMA oncology [JAMA Oncol] 2023 Feb 01; Vol. 9 (2), pp. 188-196.

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.

Autor: Lee LYW; Department of Oncology, University of Oxford, Oxford, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. Electronic address: lennard.lee@oncology.ox.ac.uk., Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ionescu MC; UK Health Security Agency, London, UK., Little M; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Tilby M; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Tripathy AR; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Mckenzie HS; Oncology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Al-Hajji Y; Birmingham Medical School, University of Birmingham, Birmingham, UK., Barnard M; UK Health Security Agency, London, UK., Benny L; UK Health Security Agency, London, UK., Burnett A; NHS England, London, UK; NHS Improvement, London, UK., Cattell EL; Department of Cancer, Taunton and Somerset NHS Foundation Trust, Taunton, UK., Charman J; National Disease Registration Service, NHS Digital, London, UK., Clark JJ; Department of Surgery and Cancer, Imperial College London, London, UK., Khan S; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Ghafoor Q; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Illsley G; UK Health Security Agency, London, UK., Harper-Wynne C; Kent Oncology Centre, University of Kent and Kent and Medway Medical School, Maidstone, UK., Hattersley RJ; Department of Oncology, Torbay Hospital NHS Foundation Trust, Torquay, UK., Lee AJX; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK., Leonard PC; Cancer Services, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Liu JKH; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Pang M; Department of Health and Social Care, London, UK., Pascoe JS; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Platt JR; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Potter VA; Department of Oncology, University Hospital Coventry and Warwickshire, Coventry, UK., Randle A; Royal College of Physicians, London, UK., Rigg AS; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Robinson TM; Population Health Sciences, University of Bristol, Bristol, UK., Roques TW; Cancer Services, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Roux RL; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Rozmanowski S; Department of Health and Social Care, London, UK., Tuthill MH; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Watts I; Department of Academic Oncology, Royal Free Hospital, London, UK., Williams S; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Iveson T; Cancer Sciences, University of Southampton, Southampton, UK., Lee SM; UCL Cancer Institute, University College London Hospitals NHS Trust and University College London, London, UK; CRUK Lung Cancer Centre of Excellence, University College London Hospitals NHS Trust and University College London, London, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Middleton M; Department of Oncology, University of Oxford, Oxford, UK., Protheroe A; Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Fittall MW; Cancer Services, The Royal Marsden NHS Foundation Trust, London, UK., Fowler T; UK Health Security Agency, London, UK., Johnson P; NHS England, London, UK; Cancer Sciences, University of Southampton, Southampton, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Jun; Vol. 23 (6), pp. 748-757. Date of Electronic Publication: 2022 May 23.

Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels.

Autor: Heyden A; Department for Neurochemistry & Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany. as.heyden@googlemail.com, Ionescu MC, Romorini S, Kracht B, Ghiglieri V, Calabresi P, Seidenbecher C, Angenstein F, Gundelfinger ED

Publikováno v: Cell and tissue research [Cell Tissue Res] 2011 Oct; Vol. 346 (1), pp. 11-26. Date of Electronic Publication: 2011 Sep 21.